In addition, high economic and increased outsourcing to emerging countries serves as a significant growth opportunity for the growth of this market. However, maintaining product quality and protection of proprietary knowledge is hindering the growth of this market.
Download Free PDF Sample Copy of the Report (with COVID-19 Impact Analysis): rnhttps://www.meticulousresearch.com/download-sample-report/cp_id=5226
IVD Contract Manufacturing Services Market: Future Outlook
The IVD contract manufacturing services market study presents historical market data in terms of values (2019 and 2020), estimated current data (2021), and forecasts for 2028. The market is segmented by Service Type (Assay Development Services, Manufacturing Services, Other Services), Category (Reagents & Consumables, Instruments & Systems), and Technology (Immunoassay, Clinical Chemistry, Microbiology, Molecular Diagnostics, Haematology, Urinalysis). The study also evaluates industry competitors and analyses the market at the regional and country levels.
Scope of the Report:
IVD Contract Manufacturing Services Market, by Type
Manufacturing Services
Assay Development Services
Other Services
IVD Contract Manufacturing Services Market, by Category
Reagents & Consumables
Instruments & Systems
IVD Contract Manufacturing Services Market, by Technology
Immunoassay
Molecular Diagnostics
Clinical Chemistry
Microbiology
Haematology
Urinalysis
IVD Contract Manufacturing Services Market, by Geography
North America
o U.S.
o Canada
Europe
o Germany
o France
o U.K.
o Italy
o Spain
o Rest of Europe (RoE)
Asia-Pacific (APAC)
o China
o Japan
o India
o Rest of APAC (RoAPAC)
Latin America
Middle East & Africa
To Gain More Insights into The Market with a Detailed Table of Content And Figures, Click Here:https://www.meticulousresearch.com/product/ivd-contract-manufacturing-services-market-5226
Based on service type, the manufacturing services segment is expected to account for the largest share of the IVD contract manufacturing services market in 2021. The large market share of this segment is mainly due to IVD companies outsourcing the manufacturing of IVD products to fulfill the increasing demand for these products for diagnosis purposes. Additionally, these services provide full production management, flexibility in scale and process, and quality and regulatory support, which further contribute to the growth of this market.
Based on technology, the immunoassay segment is expected to grow at the fastest CAGR during the forecast period. Factors such as higher preference for immunodiagnostics tests by practitioners due to its high accuracy standards, inherent specificity, high throughput, high sensitivity, and the emergence of advanced diagnostic immunoassay formats contribute to the high growth rate of this segment.
The increasing use of immunoassays in Point of Care (PoC) infectious disease testing, the growing need for developing novel tests, increasing usage of miniaturized devices, rising demand attributed to the aging population, and rising trend of automation in immunoassay instruments further drive the growth of this segment.
Based on category, the IVD contract manufacturing services market is segmented into reagents & consumables and instruments & systems. In 2021, the reagents & consumables segment is expected to account for the larger share of the IVD contract manufacturing services market. The continuous use of reagents and consumables to diagnose various prevalent diseases is the major factor attributed to the growth of this segment.
This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America, and the Middle East & Africa.
In 2021 North America is expected to account for the largest share of the IVD contract manufacturing services market, followed by Europe and Asia-Pacific. The rising prevalence of various infectious diseases, growing healthcare sector, increasing awareness regarding early disease diagnosis, growing adoption of advanced innovative diagnostic products, and increasing funding activities coupled with novel advanced development diagnostic technologies are the factors driving the growth of this market in North America.
The key players operating in the IVD contract manufacturing services market include Savyon Diagnostics (Israel), KMC Systems, Inc. (U.S.), Cenogenics Corporation (U.S.), Nova Biomedical (U.S.), Cone Bioproducts (U.S.), Invetech, Inc. (Australia), Avioq, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), In Vitro Diagnostics Developers Inc. (U.S.), LRE Medical (Germany), TCS Biosciences Ltd (U.K.), Affinity Life Sciences, Inc. (U.S.), CorisBioConcept (Belgium), Affinity Biologicals Inc. (Canada), Biokit S.A. (Spain), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), and Maxim Biomedical, Inc. (U.S.).
You can Buy Report from Here: https://www.meticulousresearch.com/Checkout/18297410
Key questions answered in the report:
Which are the high growth market segments in terms of service type, category, technology, and regions/countries?
What was the historical market for IVD contract manufacturing services across the globe?
What are the market forecasts and estimates for the period 20212028?
What are the major drivers, restraints, challenges, opportunities, and trends in the IVD contract manufacturing services market?
Who are the major players in the IVD contract manufacturing services market?
How is the competitive landscape and who are the market leaders in the IVD contract manufacturing services market?
What are the recent developments in the IVD contract manufacturing services market?
What are the different strategies adopted by the major players in the IVD contract manufacturing services market?
What are the geographical trends and high growth regions/countries?
Discussion about this post